Published in Am J Med on December 20, 1985
Food induced changes in theophylline absorption from a once-a-day theophylline product. Br J Clin Pharmacol (1986) 1.23
The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation. Br J Clin Pharmacol (1987) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol (1988) 3.57
Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med (1999) 3.34
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med (1998) 2.96
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51
Identification of a Brazil-nut allergen in transgenic soybeans. N Engl J Med (1996) 2.41
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med (2000) 2.29
Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2000) 2.18
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest (1994) 1.83
Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med (1997) 1.72
Association of rhinovirus infections with asthma. Clin Microbiol Rev (1999) 1.70
Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol (1992) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Evolution of dry powder inhaler design, formulation, and performance. Respir Med (2002) 1.55
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Chest (1999) 1.51
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol (1998) 1.33
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis (1992) 1.33
Peanut oil is not allergenic to peanut-sensitive individuals. J Allergy Clin Immunol (1981) 1.32
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol (2001) 1.32
Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med (1998) 1.30
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. Science (1976) 1.27
In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am Rev Respir Dis (1985) 1.27
Thyroid disease and asthma. J Allergy Clin Immunol (1977) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
NIH conference. Asthma. Ann Intern Med (1994) 1.22
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20
Sulfites in foods: uses, analytical methods, residues, fate, exposure assessment, metabolism, toxicity, and hypersensitivity. Adv Food Res (1986) 1.20
Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med (1978) 1.18
Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol (2000) 1.17
Early life origins of asthma. J Clin Invest (1999) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol (2000) 1.15
Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med (1996) 1.15
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med (1995) 1.14
The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol (2000) 1.14
Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1. J Immunol (1996) 1.13
Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents across the school year. J Interferon Cytokine Res (1997) 1.12
Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am Rev Respir Dis (1977) 1.12
The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J Respir Crit Care Med (1997) 1.11
The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med (1998) 1.11
The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med (1997) 1.11
Environmental allergen avoidance: an overview. J Allergy Clin Immunol (2001) 1.10
The role of viral infections in the natural history of asthma. J Allergy Clin Immunol (2000) 1.09
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med (1995) 1.09
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis (1993) 1.08
Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy (2006) 1.07
Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol (1996) 1.07
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol (2000) 1.06
Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol (1998) 1.05
Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol (1995) 1.04
Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol (1998) 1.04
Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest (1981) 1.03
Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03
Asthma. JAMA (1997) 1.02
Immunology of a serum sickness/vasculitis reaction secondary to streptokinase used for acute myocardial infarction. Clin Exp Rheumatol (1989) 1.02
Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol (1988) 1.01
Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol (1985) 1.00
Impairment of isoproterenol, H2 histamine, and prostaglandin E1 response of human granulocytes after incubation in vitro with live influenza vaccines. Am Rev Respir Dis (1979) 1.00
Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads. J Immunol Methods (1996) 0.99
Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis (1993) 0.98
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respir Med (2009) 0.98
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol (1999) 0.97
Decreased H2 histamine response of granulocytes of asthmatic patients. J Clin Invest (1977) 0.97
The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am Rev Respir Dis (1989) 0.96
A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy (2004) 0.96
Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med (1997) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Isoproterenol inhibition of isolated human neutrophil function. J Allergy Clin Immunol (1984) 0.95
Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects. J Allergy Clin Immunol (1978) 0.95
A critical evaluation of clinical trials in reactions to sulfites. J Allergy Clin Immunol (1986) 0.95
Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis (1990) 0.94
Asthma exacerbations. 2: aetiology. Thorax (2006) 0.94
The laboratory evaluation of IgE antibody to metabisulfites in patients skin test positive to metabisulfites. J Allergy Clin Immunol (1988) 0.94
A review of Alternaria alternata sensitivity. Rev Iberoam Micol (2001) 0.94
Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1999) 0.93
The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol (2000) 0.93
Prevalence of sensitivity to sulfiting agents in asthmatic patients. Am J Med (1986) 0.91
Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol (1998) 0.91
Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta. Am J Respir Cell Mol Biol (1995) 0.91
The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol (1991) 0.90
The relationship of sputum eosinophilia and sputum cell generation of IL-5. J Allergy Clin Immunol (2000) 0.90
Food allergens: structure and immunologic properties. Ann Allergy (1987) 0.90
Release of lysosomal enzyme beta-glucuronidase from isolated human eosinophils. J Allergy Clin Immunol (1988) 0.90
Allergic reaction to latex: a risk factor for unsuspected anaphylaxis. Allergy Proc (1991) 0.90